Ortivus Soars as U.K. Order Negotiations Resume: Stockholm Mover

Ortivus AB (ORTIB), a supplier of mobile monitoring and communication equipment to the emergency-care industry, rose the most in more than six weeks in Stockholm trading after contract negotiations resumed in the U.K.

The shares climbed as much as 3.6 kronor, or 59 percent, to 9.75 kronor, their steepest advance since June 10. The stock traded 53 percent higher as 11:05 a.m. local time, giving the company a market value of 198 million kronor ($31 million).

Ortivus will resume contract negotiations with the U.K.’s National Health Service about an order for electronic patient journals to some 1,800 ambulances in southern England, it said in a statement today. The shares slumped 16 percent on June 26, when it announced that a third party had appealed a decision by the NHS to start final negotiations with Ortivus for the order.

“We are now ready to start a project that will have a significant impact for Ortivus,” the Swedish company’s Chief Executive Officer Carl Ekvall said in today’s statement.

To contact the reporter on this story: Katarina Gustafsson in Stockholm at kgustafsson@bloomberg.net

To contact the editor responsible for this story: Celeste Perri at cperri@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.